Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection
- PMID: 1646329
Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection
Abstract
We determined the relationship between cardiac angiotensin-converting enzyme (ACE) inhibition and anti-ischemic efficacy of several structurally different ACE inhibitors or their prodrug esters perfused through the isolated rat heart. Seven ACE inhibitors inhibited cardiac ACE to varying degrees due to differences in uptake during perfusion through nonischemic rat hearts. Zofenopril-sulfhydryl and fosinoprilic acid were the most effective of the free inhibitors. Among the prodrugs, zofenopril and S-benzoylcaptopril, hydrolyzed rapidly by cardiac esterase, were more effective than their component ACE-inhibitors, whereas fosinopril, ramipril and enalapril were poorly active. For studies in ischemic rat hearts, vehicle or drug treatment was initiated 10 min before a 25-min period of global ischemia and during a 30-min reperfusion period. Of five unesterified ACE inhibitors studied for anti-ischemic activity, only captopril and zofenopril-sulfhydryl were found to improve postischemic contractile function and reduce cell death in the isolated rat hearts. Fosinoprilic acid, ramiprilat and enalaprilat were not cardioprotective at high perfusion concentrations, despite the fact that nearly complete inhibition of cardiac ACE was achieved with all of the compounds studied. The S-benzoyl prodrugs of zofenopril-sulfhydryl and captopril were at least as potent as their component ACE inhibitors in reducing ischemic-reperfusion damage in the same model. Neither zofenopril nor captopril, however, had any effect on coronary flow before or after ischemia. Thus, it appears that the cardioprotective effects of zofenopril and captopril are independent of cardiac ACE inhibition or, at least, that ACE inhibition alone is not sufficient. Both captopril and zofenopril are sulfhydryl-containing compounds whereas the inactive compounds are not; and, thus, this group appears to be important in mediating their cardioprotective actions.
Similar articles
-
Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).Br J Clin Pharmacol. 1989;28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. doi: 10.1111/j.1365-2125.1989.tb03587.x. Br J Clin Pharmacol. 1989. PMID: 2557876 Free PMC article.
-
Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors.Cardiovasc Drugs Ther. 1992 Aug;6(4):437-43. doi: 10.1007/BF00054194. Cardiovasc Drugs Ther. 1992. PMID: 1387799
-
Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?Circulation. 1988 Jun;77(6 Pt 2):I30-9. Circulation. 1988. PMID: 2836109
-
Newer ACE inhibitors. A look at the future.Drugs. 1990 Dec;40(6):800-28. doi: 10.2165/00003495-199040060-00004. Drugs. 1990. PMID: 2078997 Review.
-
Physicochemical and enzyme binding kinetic properties of a new angiotensin-converting enzyme inhibitor ramipril and their clinical implications.Clin Physiol Biochem. 1990;8 Suppl 1:44-52. Clin Physiol Biochem. 1990. PMID: 2147879 Review.
Cited by
-
Role of cardiac renin-angiotensin system in sarcoplasmic reticulum function and gene expression in the ischemic-reperfused heart.Mol Cell Biochem. 2000 Sep;212(1-2):227-35. Mol Cell Biochem. 2000. PMID: 11108155
-
Early Treatment With Zofenopril and Ramipril in Combination With Acetyl Salicylic Acid in Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results of a 5-Year Follow-up of Patients of the SMILE-4 Study.J Cardiovasc Pharmacol. 2017 May;69(5):298-304. doi: 10.1097/FJC.0000000000000473. J Cardiovasc Pharmacol. 2017. PMID: 28195948 Free PMC article.
-
Cardioprotective Role of Captopril: From Basic to Applied Investigations.Int J Mol Sci. 2025 Jul 25;26(15):7215. doi: 10.3390/ijms26157215. Int J Mol Sci. 2025. PMID: 40806350 Free PMC article. Review.
-
Can clonidine, enoximone, and enalaprilat help to protect the myocardium against ischaemia in cardiac surgery?Heart. 1996 Sep;76(3):207-13. doi: 10.1136/hrt.76.3.207. Heart. 1996. PMID: 8868976 Free PMC article. Clinical Trial.
-
Comparison of the effects of EXP3174, an angiotensin II antagonist and enalaprilat on myocardial infarct size in anaesthetized dogs.Br J Pharmacol. 1993 Nov;110(3):969-74. doi: 10.1111/j.1476-5381.1993.tb13908.x. Br J Pharmacol. 1993. PMID: 8298820 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous